Shandong Weigao Blood Purification Products (603014.SH) plans to change its securities abbreviation to "Weigao Biotech"
Shandong Weigao Blood Purification Products (603014.SH) announced that the company's proposed new name is Shandong Weigao Life Technology Co., Ltd. (subject to approval by the market supervision and administration authority), and the proposed new securities abbreviation is "Weigao Biotech". The securities code "603014" remains unchanged.
Shandong Weigao Blood Purification Products (603014.SH) announced that the company's proposed new name is Shandong Weigao Life Technology Co., Ltd. (subject to approval by the market supervision and administration authority), and the proposed new securities abbreviation is "Weigao Biotech"; the securities code "603014" remains unchanged.
Related Articles
AI megabet backfires! SoftBank (SFTBY.US) posts massive Q2 loss of $7.1 billion, dragged down by data center project writedowns and weakening tech stock holdings.
Harbin Pharmaceutical Group (600664.SH): Ceftizoxime Sodium for Injection Passes Generic Drug Consistency Evaluation
HK Stock Market Move | Gold mining stocks regain momentum as falling oil prices ease energy inflation concerns; market eyes tonight's CPI data.
AI megabet backfires! SoftBank (SFTBY.US) posts massive Q2 loss of $7.1 billion, dragged down by data center project writedowns and weakening tech stock holdings.
Harbin Pharmaceutical Group (600664.SH): Ceftizoxime Sodium for Injection Passes Generic Drug Consistency Evaluation
HK Stock Market Move | Gold mining stocks regain momentum as falling oil prices ease energy inflation concerns; market eyes tonight's CPI data.
